Insulin resistance is a primary cause of weight gain, especially in individuals with conditions like hypothyroidism and PCOS (Polycystic Ovary Syndrome)
Treatment duration depends on the underlying condition and clinical response
Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context
In research communities, these peptides are often discussed as complementary rather than directly competitive because: GHK-Cu is often chosen for collagen, skin, scar, and cosmetic tissue remodeling goals BPC-157 is often chosen for tendon, ligament, joint, muscle, and deeper recovery goals For that reason, many researchers discussing GHK-Cu vs BPC-157 eventually decide the better question is not which one is better, but which one better matches the tissue target? If you are building a broader research setup, you may also want to browse our research peptide collection for compatible inventory planning